Emerg Infect Dis. 2021 Nov;27(11):2810-2817. doi: 10.3201/eid2711.210552.
This retrospective multicenter cohort study assessed temporal changes in the severity and mortality rate of blastomycosis in Quebec, Canada, and identified risk factors for death in patients with blastomycosis in 1988-2016. The primary outcome was 90-day all-cause deaths. Among 185 patients, 122 (66%) needed hospitalization and 30 (16%) died. We noted increases in the proportion of severe cases, in age at diagnosis and in the proportion of diabetic and immunocompromised patients over time. Independent risk factors for death were age (adjusted odds ratio [aOR] 1.04, 95% CI 1.00-1.07), immunosuppression (aOR 4.2, 95% CI 1.5-11.6), and involvement of >2 lung lobes (aOR 5.3, 95% CI 1.9-14.3). There was no association between the Blastomyces genotype group and all-cause mortality. The proportion of severe cases of blastomycosis has increased in Quebec over the past 30 years, partially explained by the higher number of immunosuppressed patients.
这项回顾性多中心队列研究评估了加拿大魁北克地区球孢子菌病严重程度和死亡率的时间变化,并确定了 1988 年至 2016 年间球孢子菌病患者死亡的危险因素。主要结局是 90 天全因死亡率。在 185 名患者中,122 名(66%)需要住院治疗,30 名(16%)死亡。我们注意到严重病例的比例、诊断时的年龄以及糖尿病和免疫功能低下患者的比例随着时间的推移而增加。死亡的独立危险因素是年龄(调整后的优势比[aOR]1.04,95%CI1.00-1.07)、免疫抑制(aOR4.2,95%CI1.5-11.6)和累及>2 个肺叶(aOR5.3,95%CI1.9-14.3)。球孢子菌基因型组与全因死亡率之间没有关联。在过去 30 年中,魁北克地区球孢子菌病的严重病例比例有所增加,这部分是由于免疫抑制患者数量的增加所致。